Orexigen Investors Can Get Litigation Insight From Vivus Orexigen (NASDAQ:OREX) investors got a bit of bad news this week, when Actavis Laboratories (NYSE:ACT) filed an ANDA application with the FDA to manufacture ... If Actavis wins, it can make and market a drug that is less expensive than anyone else in ... 04/24/2015 - 1:31 am | View Link
Highly anticipated weight-loss pill wins FDA approval The FDA initially rejected Vivus' drug in 2010 over concerns that it can cause birth defects if taken by pregnant women. The agency laid out a risk-management plan Tuesday specifically designed to minimize the chance of the women becoming pregnant while ... 07/18/2012 - 3:26 am | View Link
Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day Vivus has been pushing for more than two years to get its new obesity drug cleared for sale by the FDA, and after one last long, confusing day, it finally got its wish. The FDA said today that the Mountain View, CA-based company (NASDAQ: VVUS) has gotten ... 07/17/2012 - 12:35 pm | View Link
Second Diet Drug Wins FDA Approval In approving the drug, FDA signaled its intent that the drug's use be tightly controlled. For example, the drug's label will include a number of contraindications, and Vivus, the company that is marketing the drug, will be required to complete 10 ... 07/16/2012 - 9:00 pm | View Link
Vivus Wins FDA Approval MINYANVILLE ORIGINAL Vivus (VVUS) shareholders got a piece of good news late last week when the Food and Drug Administration approved the ... a decision on market clearance in April but the FDA delayed doing so until July 17. "The majority of the value ... 04/30/2012 - 12:40 pm | View Link
VIVUS, Inc. (VVUS) News Headlines VIVUS, Inc. (VVUS) News – Find the latest company news headlines for VIVUS, Inc. and all the companies you research at NASDAQ.com 04/25/2015 - 3:32 am | View Website
Vivus View detailed financial information, real-time news, videos, quotes and analysis on Vivus (NASDAQ:VVUS). Explore commentary on Vivus and hear what the experts at ... 04/24/2015 - 8:44 pm | View Website
BioWorld | The Daily Biopharmaceutical News Source Contains business, science, and regulatory news, including mergers and collaborations, FDA hearings and results, and research breakthroughs. Need subscription to use. 04/24/2015 - 3:08 pm | View Website
Vivus' Suit Against Actavis Gets Some Dates Vivus (NASDAQ:VVUS) is in a litigation battle with Actavis (NYSE:ACT) with regard to the anti-obesity drug Qsymia. Last year Actavis filed an application with the FDA ... 03/6/2015 - 10:22 pm | View Website
The Newest FDA-Approved Obesity Drug Is Also the Oldest Novo Nordisk gains FDA approval for Saxenda, which is already approved as an obesity treatment called Victoza. - Brian Orelli - Health Care 12/27/2014 - 7:59 am | View Website
John Guevara, a novice politician in Fairfax County, took the Republican nomination for the county’s Sully District supervisor Saturday in a firehouse canvass election that drew just 1,362 voters. Guevara collected 478 votes during the election at Westfield High School in Chantilly to replace retiring Supervisor Michael R. Frey. John L.
The Royal Blue coup took shape with a single word.“Tag!” O’Connell softball Coach Tommy Orndorff commanded. Elizabeth Hoeymans was “it,” and the freshman dutifully retreated to the third base bag, where she awaited further orders. Orndorff crept within inches of his ward, hands on his knees like a runner himself, all while keeping stock of the flyball heading toward left field at Lake Braddock.